Bladder Cancer Indication Withdrawn for Durvalumab
After failing to improve overall survival in unresectable metastatic bladder cancer in a phase 3 trial, this indication will be
Read moreAfter failing to improve overall survival in unresectable metastatic bladder cancer in a phase 3 trial, this indication will be
Read more